Translating genomics to the clinical diagnosis of disorders/differences of sex development.

Translating genomics to the clinical diagnosis of disorders/differences of sex development.
Curr Top Dev Biol. 2019;134:317-375
Authors: Parivesh A, Barseghyan H, Délot E, Vilain E
Abstract
The medical and psychosocial challenges faced by patients living with Disorders/Differences of Sex Development (DSD) and their families can be alleviated by a rapid and accurate diagnostic process. Clinical diagnosis of DSD is limited by a lack of standardization of anatomical and endocrine phenotyping and genetic testing, as well as poor genotype/phenotype correlation. Historically, DSD genes have been identified through positional cloning of disease-associated variants segregating in families and validation of candidates in animal and in vitro modeling of variant pathogenicity. Owing to the complexity of conditions grouped under DSD, genome-wide scanning methods are better suited for identifying disease causing gene variant(s) and providing a clinical diagnosis. Here, we review a number of established genomic tools (karyotyping, chromosomal microarrays and exome sequencing) used in clinic for DSD diagnosis, as well as emerging genomic technologies such as whole-genome (short-read) sequencing, long-read sequencing, and optical mapping used for novel DSD gene discovery. These, together with gene expression and epigenetic studies can potentiate the clinical diagnosis of DSD diagnostic rates and enhance the outcomes for patients and families.
...

Source: Current Topics in Developmental Biology - April 20, 2019 Category: Biology Authors: Parivesh A, Barseghyan H, Délot E, Vilain E Tags: Curr Top Dev Biol Source Type: research